|Articles|September 29, 2015
Oracle Health Sciences Adds 93 Emerging Biopharma Customers
Advertisement
Oracle Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year. These include sponsors Accera and NewLink Genetics and CROs FMD K&L and 4C Pharma Solutions .
- FMD K&L adopted Oracle Health Sciences InForm to help ensure data accuracy and efficiencies.
- Accera, a biotechnology company focused on conditions affecting the central nervous system, uses cloud-based Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service to model scenarios for future trials.
- 4C Pharma Solutions and NewLink Genetics use Oracle Argus Safety for insight into product-safety issues, improved productivity, and streamlined safety reporting.
Read the full release.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Using AI Trial-Matching Tools to Accelerate Patient Access
September 8th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Using AI Trial-Matching Tools to Accelerate Patient Access
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
5